In contrast, these protective effects were abolished in MEK1DD mice which had constitutive activation of MEK signaling, indicating the protection of rigosertib against sepsis depended on inhibition of MEK/ERK signaling. This evidence concerns the gene MAP2K7 and Sepsis.